Replies to post #227600 on NorthWest Biotherapeutics Inc (NWBO)

[highwayman4life]

and yet NWBO with its own personalized platform of cancer vaccines which happens to be at the end of its PH 3 trial (for DCVax L) with very promising preliminary data sits at $.33. The current pps shows the market thinks this trial has already failed and is a scam.

I personally believe we get a "win" here but the pps will never be that of similar clinical phase companies and even with stat sig data I don't think we ever get an honest valuation for potential of the DCVax platform.

The damage has been done and call it whatever you want...piss poor management or wolf pack, this Company despite making it to the finish line has endured irreparable damage.

GLTA

[notbrad]

What I can't get over is that this company went public 5 months ago, still in phase 1 clinical, and they have a $7B market cap!